Lung cancer surgery study for specific nodule types
Part of Cancer clinical trials.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a good performance status (able to carry out daily activities without help).
- You have never had lung cancer surgery or chemotherapy or radiation therapy before.
- You have a lung nodule that is mostly solid (consolidation to tumor ratio between 0.5 and 1) and is 2 to 3 cm in size.
- Your cancer is confirmed to be a type called invasive lung adenocarcinoma.
- Your cancer has not spread to lymph nodes or other parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a lung surgery approach (segmentectomy) for people with early, invasive lung cancer that shows “ground-glass” on scans. It aims to see if this less extensive surgery can treat the cancer effectively when the tumor is in a specific size and scan pattern range.
This trial compares two types of surgery for early-stage lung cancer tumors that are 2-3 cm in size: removing just the affected segment of the lung (segmentectomy) or removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and may help you recover faster.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This trial compares two types of lung surgery—removing a small lung segment versus removing an entire lung lobe—for small lung adenocarcinoma (≤ 2 cm). It may help you choose the safest approach that still controls the cancer.
This trial compares two lung-surgery options for small lung adenocarcinoma (≤ 2 cm): removing a lung segment versus removing an entire lobe. It aims to see which operation controls the cancer while preserving lung function.
This study tests a type of lung surgery called segmentectomy for people whose lung cancer shrank after chemotherapy or immunotherapy. The goal is to see if removing just the tumor part is safe and effective.
Hear when a new Segmentectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.